Category Archives: HPV Vaccine“What concerns us is that the two manufacturers of the vaccine aren’t always using facts. They claim that a lot of high-risk strains of cancer-causing virus are protected against but equally there are others that are not. If protection is not more than 20 per cent then that is an awful lot of money to be spending, particularly as the vaccines have quite serious side-effects.” — Professor Martina Doren, of the Charitie Hospital in Berlin:
All around the world concerns are mounting about the effectiveness and the safety of the HPV vaccines. Whilst many of our Governments refuse to listen to public concern and ignore the ever increasing numbers of children who have had adverse reactions to the Gardasil and Cervarix vaccines, in Germany their concerns are at last being looked at and examined carefully. The Robert Koch Institute in Germany which makes recommendations on the public funding of vaccines, is reviewing its vaccination programme after 13 experts called for a reassessment of its HPV vaccination programme and an end to “misleading information” about the effectiveness of the HPV-vaccine.
The medical staff refused to take part because they did not have enough experience with the vaccine and were concerned about possible side effects, a spokesman for youth health services in Brabant told the paper. Doctors’ organization LAD refused to say how many were involved. But a spokesman said it is the first time doctors have registered a formal refusal to vaccinate.
Richard B.S. Roden, a researcher at Johns Hopkins who was trained at the National Cancer Institute, has spent a decade developing the new HPV-vaccine. He said it will protect against a wider range of HPV types than Gardasil and can be produced for perhaps less than $1 a dose.
Genital HPV infection is a sexually transmitted disease caused by human papillomavirus (HPV), a group of viruses that includes more than 100 different strains or types. Most people who become infected with HPV will not have any symptoms and will clear the infection on their own. HPV is the most common sexually transmitted infection and contracting it does not mean it is a death sentence.
Follow The Money… Merck has a growing economic interest in Virginia. In December 2006, Merck announced it would invest $57 million to expand its Elkton, Va., plant to make Gardasil, helped by a $700,000 grant from a state economic development agency that is part of the executive branch. Two months later, Gov. Tim Kaine, who [...]
Opportunistic marketing isn’t new. Mass merchandising of tobacco products to minors delivered millions of “Hooked for Life” or at least until premature death ‘users” for BIG TOBACCO. With recent regulations that allegedly limited marketing tobacco to minors, rapacious advertising agencies and armies of mercenaries (lobbyists) have moved to a new, even more, profitable venue —BIG [...]
FINALLY! In June of 2006, my writing partner, Leslie Botha, and I, started writing articles cautioning women against the use of Gardasil® for girls and young women. We cited the limited nature of the clinical trials (the number, and ages of women tested) and the length of time from the clinical trials and the FDA [...]
In a previous Inconvenient Woman Blog entry we noted the death of 17 year old Jessica Ericzon, “an all-American teenager,” whose tragic death has been tied to the Merck vaccine Gardasil®. Jefferson County Medical Examiner Samuel Livingstone, reported Jessie’s death to the federal Vaccine Adverse Events Reporting System. Her family started the Jessica Ericzon Memorial [...]
More Reports of Coincidental Collateral Damage Reported by Barbara Loe Fisher The reports of HPV vaccine reactions, injuries and deaths continue to roll in, not only to NVIC but also to the federal Vaccine Adverse Events Reporting System (Search HPV4 at: http://www.medalerts.org/vaersdb/index.html) newspapers, and television stations. And the only response that comes from officials at [...]
© 2002- An Inconvenient Woman. Site design and construction by Pleiades Publishing Services, Co.
Powered by Wordpress and based on the template design MyJournal Hypereal by 
BlogoSquare
